Intuitive Surgical, Inc. $ISRG Shares Purchased by Czech National Bank

Czech National Bank grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.9% in the 3rd quarter, Holdings Channel reports. The firm owned 91,046 shares of the medical equipment provider’s stock after acquiring an additional 3,436 shares during the quarter. Czech National Bank’s holdings in Intuitive Surgical were worth $40,719,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Norges Bank bought a new position in Intuitive Surgical during the 2nd quarter worth $2,569,260,000. Vanguard Group Inc. boosted its holdings in shares of Intuitive Surgical by 2.1% during the second quarter. Vanguard Group Inc. now owns 33,335,833 shares of the medical equipment provider’s stock valued at $18,115,025,000 after acquiring an additional 670,302 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in shares of Intuitive Surgical by 20.1% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 3,393,951 shares of the medical equipment provider’s stock worth $1,680,922,000 after acquiring an additional 566,979 shares during the last quarter. Jennison Associates LLC increased its holdings in shares of Intuitive Surgical by 20.4% in the 2nd quarter. Jennison Associates LLC now owns 3,122,390 shares of the medical equipment provider’s stock worth $1,696,738,000 after acquiring an additional 528,359 shares during the period. Finally, Bessemer Group Inc. lifted its position in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock valued at $428,386,000 after purchasing an additional 371,806 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

ISRG opened at $556.86 on Thursday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock’s fifty day moving average is $536.26 and its 200-day moving average is $505.77. The company has a market capitalization of $199.62 billion, a PE ratio of 73.66, a P/E/G ratio of 5.10 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same quarter last year, the business posted $1.84 earnings per share. The company’s quarterly revenue was up 22.9% on a year-over-year basis. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the stock. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Monday. Daiwa Capital Markets raised their target price on Intuitive Surgical from $510.00 to $550.00 and gave the company an “outperform” rating in a research report on Friday, October 24th. Argus lifted their target price on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. UBS Group set a $600.00 price target on Intuitive Surgical and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Finally, Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of “Moderate Buy” and a consensus target price of $609.83.

Insider Buying and Selling

In related news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president directly owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO David J. Rosa sold 24,500 shares of the stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at approximately $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 114,007 shares of company stock worth $63,533,844. 0.70% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.